Alliance Pharma PLC | Income Statement
Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
45,275.00
43,536.00
48,344.00
97,492.00
103,315.00
118,208
Cost of Goods Sold (COGS) incl. D&A
18,366.00
18,981.00
19,813.00
42,735.00
44,630.00
45,771
Gross Income
26,909.00
24,555.00
28,531.00
54,757.00
58,685.00
72,437
SG&A Expense
13,549.00
13,081.00
16,249.00
29,446.00
32,883.00
41,587
EBIT
-
11,474.00
-
25,311.00
25,802.00
30,850
Unusual Expense
-
622.00
3,736.00
969.00
4,932.00
6,773
Non Operating Income/Expense
109.00
10.00
52.00
693.00
534.00
2,083
Interest Expense
1,244.00
1,072.00
1,221.00
3,226.00
3,022.00
3,422
Pretax Income
12,057.00
9,838.00
14,988.00
21,920.00
28,350.00
22,790
Income Tax
2,425.00
1,772.00
2,490.00
4,127.00
541.00
4,447
Equity in Affiliates
48.00
319.00
194.00
299.00
19.00
13
Consolidated Net Income
9,584.00
8,385.00
12,692.00
18,092.00
28,910.00
18,356
Net Income
9,584.00
8,385.00
12,692.00
18,092.00
28,910.00
18,356
Net Income After Extraordinaries
9,584.00
8,385.00
12,692.00
18,092.00
28,910.00
18,356
Net Income Available to Common
9,584.00
8,385.00
12,692.00
18,092.00
28,910.00
18,356
EPS (Basic)
0.04
0.03
0.05
0.04
0.06
0.04
Basic Shares Outstanding
250,836.30
264,148.40
272,729.20
469,423.80
473,842.80
497,199.60
EPS (Diluted)
0.04
0.03
0.05
0.04
0.06
0.04
Diluted Shares Outstanding
265,010.90
265,603.40
279,051.80
474,248.40
479,123.90
510,422.80
EBITDA
14,048.00
12,269.00
12,720.00
25,740.00
26,735.00
32,396
Non-Operating Interest Income
50.00
48.00
139.00
111.00
104.00
52
About Alliance Pharma
View Profile
